Navigation Links
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
Date:7/14/2014

ether as a result of new information, future events and developments or otherwise, except as required by law.

Important Information for Investors and Shareholders

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the proposed transaction between Mallinckrodt and Questcor, Mallinckrodt has filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 containing a joint proxy statement of Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt. The registration statement on Form S-4 was declared effective by the SEC on July 11, 2014. Each of Mallinckrodt and Questcor will commence mailing the joint proxy statement/prospectus to its respective shareholders as soon as possible. INVESTORS AND SECURITY HOLDERS OF MALLINCKRODT AND QUESTCOR ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT HAVE BEEN OR WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders can obtain free copies of the joint proxy statement/prospectus, the registration statement and other documents filed with the SEC by Mallinckrodt and Questcor through the website maintained by the SEC at http://www.sec.gov.  

Participants in the Merger Solicitation

Mallinckrodt, Questcor, their respective directors and certain of their executive officers and employees may be considered participants in the solicitation of proxies in connection with the proposed transaction.  Information regarding the persons who may, u
'/>"/>

SOURCE Mallinckrodt plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
2. Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
3. Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application
4. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
5. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aegerion Pharmaceuticals, Inc.
11. Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: ... A. Martell , to the position of Executive Chairman. ... KaloBios Board of Directors. In this new role, he ... to refine and execute on the strategic plan to ... therapeutics for orphan oncology indications with high unmet medical ...
(Date:5/28/2015)... THE WOODLANDS, Texas , May 28, 2015 /PRNewswire/ ... announced today that Lexicon management will present at the ... at 8:00 a.m. Eastern Time in New ... of Lexicon,s clinical development programs and milestones. ... Lexicon,s website at www.lexpharma.com . An archived version ...
(Date:5/28/2015)... SOUTH SAN FRANCISCO, Calif. , May 28, 2015 ... the treatment of cancer, today announced that Sean ... at the upcoming Jefferies 2015 Global Healthcare Conference ... 2:30 p.m. EDT on Tuesday, June 2, 2015. Dr. ... including the company,s Precision cancer immunotherapy and Probody drug ...
Breaking Medicine Technology:KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5Lexicon To Present At The Jefferies 2015 Healthcare Conference 2
... FRANCISCO, July 21, 2011 ClinStar, LLC , ... and Eastern Europe to the pharmaceutical and biotechnology industry, ... speak at Marcus Evans 6th Annual Clinical Research ... FL.    (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ) ...
... July 21, 2011 Endologix, Inc. (NASDAQ: ELGX ... today announced financial results for the three and six months ... and Chief Executive Officer, said, "We are pleased with our ... our growth and new product development goals for 2011.  In ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 The Boys ... of $2,500 from Horizon Blue Cross Blue Shield of New ... golfer Natalie Gulbis, the club can receive much more support ... by Acer. , A former Boys & Girls Club member ... in Sacramento, California, Ms. Gulbis has accepted the Horizon Blue ...
(Date:5/28/2015)... Are policies that spell out when Medicare ... financial pain for seniors? That’s what a study published ... set to figure out, and its findings could have ... The study, “Observation Encounters and Subsequent Nursing Facility Stays,” ... how Medicare policies that distinguish between an “inpatient” hospital ...
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Workers’ compensation costs ... typical state, a recent study by the Workers Compensation ... over a three-year period. , The WCRI study, CompScope™ ... which workers missed seven days or more of work with ... the average 2011 Michigan claim was 4 percent lower than ...
(Date:5/28/2015)... Baptist Medical Center Jacksonville has added a ... stroke or other neurological conditions. , The new Center ... in the country and the first in Florida designed ... brain aneurysms. , “Baptist Health is committed to ... are impacted by stroke,” said Nicole Thomas, Baptist Health ...
Breaking Medicine News(10 mins):Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3
... ... inactivating 99.9% of the flu virus. The filter has been treated with Coway,s anti-viral ... ... 2009 -- Coway ,s new anti-flu air filter was recently tested for ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), ... nursing, rehabilitative care services, hospice care and assisted living ... Oppenheimer & Co. 20th Annual Healthcare Conference on November ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the company,s ...
... Keystone ... and administer health screenings. , ... Philadelphia, Pa. October 27, 2009 – More than 250 West Philadelphia men, ... part of the Health Ministry Program, hosted by Keystone Mercy Health Plan, the largest ...
... ... an Impact as Inaugural President , ... Grand Rapids, Mich. (Vocus) October 29, 2009 -- Sanford-Brown Institute (SBI) - Grand ... first campus president. Amidon comes to SBI - Grand Rapids from Baker College in Muskegon, ...
... Smith & Nephew,s (NYSE: SNN ; LSE: ... first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement ... Smith & Nephew and COTA entered into a grant ... as an independent, third-party administrator of funds. Smith ...
... autoimmune disease scleroderma can discolor parts of the skin of ... harden their skin, their blood vessels, and their internal organs ... forms, scleroderma gives Dartmouth geneticist Michael Whitfield, his graduate students, ... search for the triggers of the chronic condition. In a ...
Cached Medicine News:Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2Health News:More Than 250 West Philadelphia Men, Women and Children are Expected to Attend Wellness for Life Event 2Health News:President Selected to Open Sanford-Brown Institute - Grand Rapids 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 3Health News:Geneticists hunt for scleroderma triggers 2
SPIRAL-FLEX® Oral Precut Reinforced Tubes...
SHERIDAN PREFORMED™ Endotracheal Tubes are designed to conveniently position the anesthesia circuit out of the surgical field for oral and maxillofacial procedures....
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
... is the next step in the ... is an easy to use, easy ... used as a standard tube, as ... quickly and safely handle intubations of ...
Medicine Products: